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Herpes simplex virus (HSV) infections are very common worldwide(1).They are 
caused by either HSV-1 or HSV-2, and the majority is asymptomatic(2). HSV-
2 prevalence among pregnant women has been estimated as 20%-30%, with 
approximately 10% of HSV-2 seronegative women living with a seropositive partner 
and hence, at risk in the acquisition of herpes during pregnancy (3, 4). The potential 
factors associated with HSV-2 infection are age and sex or gender. Ageing increases 
the risk of HSV (5). Other factors, such as having sexual intercourse sooner than 
common age and risky sexual relationship, poverty, gender or ethnicity, and bacterial 
vicinities can facilitate women’s risk of infection before their pregnancy (6, 7).In the 
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Abstract
Objective
Herpes Simplex virus (HSV) is one of the most common sexually transmitted 
diseases in the world. This study aimed to determine the prevalence of herpes 
simplex virus in pregnant women in Iran.
Materials & Methods
A systematic literature review was conducted to study the HSV subtypes in 
Persian and English papers through several databases. We searched Pub Med, 
Scopus, Ovid, Science Direct and national databases as Magiran, Iranmedex 
and Science Information Database (SID) up to October 2015. Random-effects 
model were applied to calculate the pooled prevalence of HSV subtypes.
Results
Five eligible studies were identified, including 1140 participants. The pooled 
prevalence of HSV infection in pregnant women was 0.64% (95% CI: 0.10-
1.18) in Iran. The pooled prevalence of studies on both HSV-1 and HSV-2 was 
0.91% (CI: 0.81-1.02) and studies on only HSV-2 was 0.23% (CI: -0.61-0.63), 
respectively.
Conclusion
The prevalence of HSV infection in pregnant women in Iran was higher. HSV 
infection of the central nervous system, especially with HSV-2, can also cause 
recurrent aseptic meningitis and monophasic, as well as radiuculitis or myelitis. 
The performance of screening to detect infection in pregnant women can play 
an important role in the prevention and treatment of patients and help to prevent 
the transmission of HSV infection to infants in Iran.
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2015.In addition, the reference lists of several studies 
and conferences related to the present study were 
investigated.
Inclusion and exclusion criteria
Studies that report on the prevalence of HSV among 
pregnant women in Iran were included while Case 
Reports, Case Series and Quasi – experiments and 
studies whose methods and results were not clear and the 
population did not comprise of Iranian pregnant women 
were excluded.
Data extraction
Independent literature searches were conducted by two 
reviewers and experts and after omitting the repeated 
cases. They chose the title and abstract studies based on 
the inclusion and exclusion criteria. The name of authors 
was blinded. If there was a problem or disagreement 
between two investigators, the third one helped them 
to solve the problem by discussion. The name of first 
author, the year of publication of article, the amount of 
sample, the number of positive virus, the type of virus 
and the place of studies extracted were analyzed.
Quality assessment of studies
To assess the quality of the studies, the STROB checklist 
was used(20). The studies were classified as high, 
intermediate and low quality.
Statistical analysis
The data obtained from the various studies were analyzed 
using a random effect with 95% confidence intervals by 
inverse variance weight. The heterogeneity between the 
included studies was assessed using Q-test and I2 index. 
By so doing, a P-value of less than 0.01% was considered 
as significant in the heterogeneity test. Thereafter, 
subgroup analysis was carried out based on virus type, 
year of publication and quality of studies. All analyses 
were performed using Review Manager Version 5.3 
software. Assessment of publication bias was planned 
by visualizing the funnel plot asymmetry. However, 
since the number of included studies was less than 
the recommended optimum number of at least 10, the 
assessment of publication bias was not carried out (21).
Results
Overall, 110 articles were obtained and after omitting the 
repeated studies, 53 articles were left. Based on analysis, 
the titles and summaries of 27 articles were selected and 
US, 22% of pregnant women are infected with HSV-2. 
Among whom two percen tare infected during pregnancy, 
which threatens them and their baby (8).Some studies 
have demonstrated the prevalence of HSV type 1 or 2 
during pregnancy(9, 10).Nearly 30%-50% of babies can 
be infected with the virus and at the end of pregnancy 
period; the risk of infection may increase (11).
The problem is not just relatively high prevalence 
of HSV infection among pregnant women, but 
unawareness of this infection, which affects newborns 
drastically (1, 12). About three-fourth of women with 
a history of HSV show incidence of HSV again during 
their pregnancy and one out of seven suffer from lesion 
through delivery(13,14).
HSV infections during pregnancy may cause fetal and 
neonatal infections. HSV transmission may occur during 
pregnancy and after delivery, 80%-90% of neonatal 
herpes infections occur when the baby passes through 
the mothers’ infected birth canal. HSV infection can 
have severe consequences for the affected newborns. 
HSV infection may turn to herpes encephalitis or 
infection across other organs such as liver, lungs, and 
kidneys with or without dermal symptoms. 
HSV causes disordering of some parts of the body, such 
as CNS, skin, eyes, lungs, mouth, adrenal gland and 
liver, and in the absence of therapy, it has a mortality 
risk of about 80% (15).Babies with the disease usually 
die because of viral pneumonia and intravascular 
coagulopathy. Survivors (babies who survived) from 
serious infection generally suffer from permanent 
neurological disorder (16-19). This study aimed to 
determine the prevalence of HSV infection in pregnant 
women in Iran.
Materials and Methods
Study eligibility and identification
We investigated to estimate the rate of HSV infection 
rates among Iranian pregnant women in Iran and the 
neurologic impact of HSV on the newborns. A literature 
search was performed in which PubMed, Scopus, Ovid 
and Science Direct as well as national databases such as 
MagIran, Iranmedex and Science Information Database 
(SID) using “Prevalence” OR “frequency” AND 
“herpes simplex virus” OR “HSV”OR “TORCH”AND 
“pregnancy” AND “Iran “as keyboards up to October 
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The prevalence of HSV was observed as 0.64%. HSV 
prevalence based on studies of both HSV-1 and HSV-2 
was observed as0.91% and studies on only HSV-2was 
observed as 0.23 %(Fig.2). Nevertheless, the primary 
statistics show that prevalence of HSV in Iran is higher 
than that developed nations and lower in comparison 
with other developing ones (27, 28).
Central nervous system disease alone occurs in one-third 
of all infants with neonatal herpes simplex virus infection 
(29). Localized herpes simplex virus have been found in 
the fifthly percent of the affected neonates, involvement 
of the central nervous system in the thirty three percent, 
and disseminated infections in the seventeen percent 
(30-31). Although HSV-1 has a predilection for the 
development of encephalitis after intracerebral injection 
in the mouse model, HSV-2 generally causes meningitis. 
However, the meninges are not the only component of 
the central nervous system involved in HSV-2 infection 
(32). Virtually any part of the neuraxis may be affected 
by this virus, including the brain, brain stem, spinal cord, 
nerve roots, cranial nerves and retina. HSV infection 
of the CNS, especially with HSV-2, can also cause 
recurrent aseptic meningitis and monophasic, as well 
as radiuculitis or myelitis (33). When HSV-2 infection 
is mentioned, neonatal herpes simplex encephalitis, a 
devastating disorder, is the disease most commonly 
considered. Seventy percent of affected neonates are 
born to mothers without symptoms or signs of genital 
herpes (34). Recent studies suggest that as much as 30% 
of neonatal herpes simplex encephalitis is due to HSV-
1. The risk of acquisition during a primary infection 
with HSV-1 or HSV-2 is the fifthly percent (34). The 
risk of development of neonatal HSE is reduced if a 
mother with primary HSV-2 genital herpetic infection is 
seropositive for HSV-1. Risk factors for neonatal HSV 
disease include first-episode maternal infection in the 
third trimester, invasive monitoring, and delivery before 
a gestational age of 38 weeks, and maternal age of less 
than 21 years. Delivery by cesarean section significantly 
reduces the risk of HSV acquisition (35).
Tehran has significantly the most prevalence of HSV in 
Iran. The high prevalence in Tehran can be attributed to 
the high population density of Tehran, numerous poor 
areas around its territory, different cultural conditions, 
different ethnicities, precocious puberty in children, high 
their texts were completely analyzed. In addition, after 
the evaluation of all articles, five of the articles were 
selected (22-26).Some studies were omitted for reasons 
such as lack of suitable and useful factors like poor design 
or lack of suitable design, and poor results or appropriate 
population. Figure 1 shows the process involved in the 
search and finding of the studies. Five studies were 
included for meta-analysis. In addition, studies carried 
out during 2003 to 2015 involving 1140 participants 
were included. Table 1 shows the characteristics of the 
studies.
The overall prevalence of HSV infection in pregnant 
women in Iran was0.64% (95% CI: 0.10-1.18) (Figure 
2). The high prevalence was observed in Tehran Province 
with 0.99 % (95% CI: 0.98- 1.00) and low prevalence 
was observed in Kermanshah Province 0.03% (95% CI: 
0.02-0.05), respectively. Moreover, based on different 
types of HSV, studies which involved both types 1and 2 
prevalence was 0.91% (95% CI: 0.81, 1.02) and studies 
that involved only type 2 prevalence was 0.23% (95% 
CI: -0.16-0.63) respectively.
Quality assessment of the studies 
Based on analyzing the quality of studies, which included 
meta-analysis according to the STROB checklist, 
two studies were of high quality, two studies were of 
intermediate quality, and a study was of low quality. 
HSV prevalence was calculated based on the quality of 
studies. Prevalence in studies with higher quality was 
more than the overall prevalence. In addition, prevalence 
in studies with lower quality was less than overall 
prevalence.
Subgroup analysis 
Table 2 shows the result of subgroup analysis based on 
the quality of studies, year of publication, place of the 
studies and sample size. 
Discussion 
HSV infection is one of the public health problems 
around the world, which infect people yearly. This virus 
poses significant problems for infected people. During 
pregnancy, this virus can be dangerous to the fetus and 
cause irreparable damage (11).This study is by our best 
of knowledge the first systematic review and meta-
analysis on the prevalence of HSV infection among 
Iran’s pregnant women. 
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recent years, the prevalence of HSV in pregnant women 
has increased. However, the high prevalence of HSV has 
also been demonstrated among young Iranian population. 
Improvement in the standard of living, which increases 
health activities, should be facilitated by the primary 
health care (PHC) providers and this can be effective in 
improving the health status of the individual. In addition, 
screening to detect infection in pregnant women can 
play an important role in the prevention and treatment 
of patients and in the prevention of its transmission to 
infants in Iran. The high HSV infection in pregnant 
women is a significant challenge for disease control and 
surveillance in Iran.
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– risk behaviors, immigration and poverty of the city. 
On the other hand, unhealthy lifestyle, lack of following 
primary health care, turning from helpful traditions and 
believes as well as low quality of life in other areas can 
result in high prevalence of HSV(36-37).
Iran is a developing country with a young population and 
many people on the verge of marriage. Some reasons, 
such as sparse population in vast area, bordering with 
Afghanistan and Iraq and many migrations from these 
countries to Iran, have changed sexual activities in 
the country. Diverse race types and cultures in Iran 
could also possibly foster the high prevalence of HSV 
(38). Although, these conditions are risky factors for 
high infection by HSV, no study has investigated the 
relationship between these factors and more infection by 
HSV.
A high heterogeneity was observed between the 
accepted studies and those analyzed based on the 
amount of P-value, statistical tests I2and Chi – Square. 
This heterogeneity can be attributed to the number 
and sample size (quantity of the sample). The meta-
analysis of studies is another reason for this statistically 
significant difference. In addition, the prevalence of this 
virus in high-qualified studies and low prevalence in low 
qualified studies could be another reason(39).
In this present study, some limitations were observed. 
Firstly, the quality of the articles, and the fact that 20% 
of the articles were of low quality could affect the results 
of this study. Secondly, the low number of systematic 
reviewers of studies and, thirdly the high number of 
articles studied in Tehran may cause bias in the results 
of this study.
In conclusion, the overall prevalence of HSV infection 
in pregnant women in Iran was observed as 0.64%. In 
Table 1. Characteristics of the Studies in Meta-Analysis
Author Year Location Sample size Type HSV
Ziayian et al. 2007 Tehran 400 Type 1and2
Pourmand et al. 2003 Kermanshah 385 Type2
Danesh shahraki et al. 2010 Esfahan 96 Type2
Bagheri joshaghani et al. 2015 Kashan 80 Type 1and2
Ghasemi et al. 2015 Tehran 179 Type 1and2
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Table 2. Subgroup Analysis HSV Infection in Pregnant Women in Iran
No studies Prevalence CI 95 % P  value
Year of publication
Before 2008 3 0.51 -0.43 to 1.45 0.284
After 2008 2 0.73 0.50 to 0.96 0.000
Quality of the studies
High 2 0.87 0.78 to 0.95 0.000
Intermediate 2 0.72 0.17 to 1.26 0.010
Low 1 0.03 0.02 to 0.05 0.000
Location of the studies 
Tehran 2 0.91 0.75 to 1.07 0.000
Other cities 3 0.46 -0.16 to 1.08 0.143
Sample size 
< 200 3 0.73 0.50 to 0.96 0.000

























Electronically and handing searching = 110 
Excluded because of duplicated = 
57 
Remained for checking title and abstract =53  
Excluded because not related to the 
objective = 26 
Remained for checking full text =27  
Excluded because not eligible = 22 
Included for meta-analysis =5 
Fig 1. Flow chart selected studies for meta-analysis
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